(MedPage Today) — GLP-1 receptor agonists were tied to a lower risk of developing epilepsy in adults with type 2 diabetes, a large U.S. study showed.
Compared with DPP-4 inhibitors, GLP-1 receptor agonist use was associated with a 16% lower risk…
Physicians want N.L. to hit pause on a mandatory, province-wide electronic health information system
Doctors in Newfoundland and Labrador says quick implementation of a province-wide electronic health information system threatens to harm patients and...
